OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	173
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	88
Conflict and Access to Health Care	55
Managing First-Line Metastatic Renal Cell Carcinoma	46
Forthcoming Issues	42
Copyright	42
Contemporary Management of Dermatofibrosarcoma Protuberans	41
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	39
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	39
Remote Telemonitoring and Telehealth in Surgical Oncology	39
Contents	38
Treatment of High-Risk Gestational Trophoblastic Neoplasia	36
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	35
Benefits and Harms of Interception and Early Detection of Cancer	30
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	30
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	22
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	21
Hematology/Oncology Clinics of North America	19
Contributors	19
Contents	18
Contributors	17
Copyright	17
Advances in Gastric Cancer Surgical Management	16
The Landscape of Personalized Medicine in Gynecologic Cancer	16
Future Directions for Gestational Trophoblastic Disease	16

Advances in Immunotherapy in Esophagogastric Cancer	15
Contents	15
Disparities in Breast Cancer Outcomes and How to Resolve Them	15
Advances in Systemic Therapy in Pancreatic Cancer	14
Foreword	14
Liposarcoma	14
Genomic Alterations in Langerhans Cell Histiocytosis	13
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer	13
Emerging Therapies in β-Thalassemia	13
Histiocytic Disorders in Pediatric and Adult Patients	13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	13
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	13
Forthcoming Issues	13
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	13
Advances in Surgical Techniques for Lung Cancer	13
Forthcoming Issues	13
Copyright	12
Skin Cancer Precursors	12
Clinical Vignettes Part I	12
Evaluation and Management of Bing–Neel Syndrome	11
Copyright	11
Genes as Medicine	11
Malignancies of the Upper Gastrointestinal Tract	11
The Evolving Role of Surgery in Multimodal Cancer Care	11
Hereditary Renal Cell Carcinoma Syndromes	11
Gestational Trophoblastic Neoplasia	10
New Developments in Myeloma	10
Advances in the Surgical Management of Esophageal Cancer	10
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	10
Patient-Reported Outcomes in Radiation Oncology	10
Management of In-Transit Metastatic Melanoma	10
Contents	10
Forthcoming Issues	9
High-Risk Non-Melanoma Skin Cancers	9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	9
Bispecific Antibodies in the Treatment of Multiple Myeloma	9
Local Control in Soft Tissue Sarcomas	9
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	8
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	8
Contents	8
Evolution of Gene Therapy, Historical Perspective	8
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?	8
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	8
Contributors	8
Forthcoming Issues	8
Contents	8
Copyright	8
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	7
Ductal Carcinoma In Situ	7
Breast Cancer in India	7

Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	7
Clinical Complications and Their Management	7
Hemophilia A/B	7
Melanoma Brain Metastasis	7
Copyright	7
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	7
Radiation-Induced Tissue Regeneration	7
Breast Cancer and Lifestyle Factors	7
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	6
Early-Stage Hodgkin Lymphoma	6
Sarcomas	6
Pathogenic Mechanisms in Thalassemia I	6
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	6
Early Detection of Precursor Diseases of Multiple Myeloma	6
Impact of Clonal Heterogeneity in Multiple Myeloma	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Copyright	6
Surgery for Recurrent Ovarian Cancer	6
Immune-Pathogenesis of Myeloma	6
FLASH Radiotherapy	6
Pathogenic Mechanisms in Thalassemia II	6
Targeted Therapy Innovations for Melanoma	6
Contributors	6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	6
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	6
Advances in Cervical Cancer	6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	6
Education and Training Models for Remote Learning	6
Genetics and Genomics of Gestational Trophoblastic Disease	5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	5
Merkel Cell Carcinoma	5
Renal Cell Cancer	5
Role of Radiation in Treatment of Renal Cell Carcinoma	5
Waldenström Macroglobulinemia	5
Smoldering Multiple Myeloma	5
Contributors	5
Contents	5
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	5
Remembering the Contributions of Professor David J. Weatherall	5
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia	5
Contents	5
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	5
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)	5
Local Therapies in Advanced Colorectal Cancer	5
Approach to High-Risk Multiple Myeloma	5
Contents	5
Forthcoming Issues	5
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	5
Regulatory Aspects of Gene Therapy	5
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia	5
Debate	5